Dr. Kimberly Sullivan co-chaired a Gulf War Illness symposium with colleague Dr. Liang Qiang at this year’s American Society for Neurochemistry conference in Kentucky. Speakers included top researchers in the field of GW Illness; Dr. Alvin Terry, Dr. Ashok Shetty, Dr. Peter Baas, and Dr. James Cai. While we don’t have their presentations, below you […]
Utilizing a mouse model of GWI, researchers examined the potential of β-adrenergic (beta-adrenergic) receptor inhibitor and anti-inflammatory drug, propranolol, as a treatment for GWI. Findings indicate that anti-neuroinflammatory drugs, such as proranolol, show promising potential in treating the underlying neuroimmune issues associated with GWI.
This article shares the study design and methods for examining the efficacy of Bacopa in treating Gulf War Illness. Bacopa monnieri is a therapeutic agent known to target neuro-immune function and inflammation.
The New England School of Acupuncture (Newton, MA) conducted the study, The Effectiveness of Individualized Acupuncture Protocols in the Treatment of Gulf War Illness: A Pragmatic Randomized Clinical Trial, in collaboration with Beth Israel Deaconess Medical Center (Boston, MA). This research found that acupuncture treatment of sufficient dose appears to offer significant relief of physical […]